Hester Biosciences Posts Strong Q2 FY27 Results; Approves Loan to Africa Arm
Hester Biosciences Ltd 路 Press Release 路 05 Nov 2026, 4:46 pm
Hester Biosciences Posts Strong Q2 FY27 Results; Approves Loan to Africa Arm Hester Biosciences reported strong consolidated Q2 FY27 earnings, with revenue rising 38% YoY to INR 979.12m and PAT increasing 44% YoY to INR 206.31m. Consolidated EBITDA grew 55% YoY to INR 365.16m, with margins expanding to 37%. Standalone revenue rose 28% YoY to INR 829.28m, while standalone PAT surged 131% YoY to INR 166.60m. Additionally, the Board approved an unsecured loan of USD 1m at 9% p.a. for a 3-year tenure to its wholly-owned subsidiary, Hester Biosciences Africa Limited, to fund working capital and corporate requirements.
Original exchange filing (PDF)
More announcements from Hester Biosciences Ltd
- 20261105 Transcript of Earnings Conference Call for Q2 & H1 FY27 Financial Results 路 07 Nov 2026
- Audio recording of the Earnings Conference Call for Q2 FY 27 路 05 Nov 2026
- Hester Biosciences Limited has informed the Exchange about Board have approved an Unsecured loan of an aggregate amount of USD 1 million to Hester Biosciences Africa Limited( Hester Africa ), foreign wholly-owned subsidiary in Tanzania, in one or more tranches. 路 05 Nov 2026
- Disclosure under regulation 30 of Listing Regulations - Board of Directors approved an unsecured loan to Hester Biosciences Africa Limited, Foreign wholly-owned subsidiary of the Company. 路 05 Nov 2026
- Hester Biosciences Limited has informed the Exchange regarding a press release dated November 05, 2026, titled "20261105 Q2 & H1 FY27 Press Release". 路 05 Nov 2026
- Hester Biosciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Outcome of Board Meeting held on 5 November 2026 and Financial Results for the Q2 & H1 FY 2026-27 路 05 Nov 2026
- This is to inform you that, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has scheduled investor .... 路 05 Nov 2026
